Le Lézard
Classified in: Health
Subject: MAT

3Fun Announces Monthly Donations Exceeding $10,000 to American Sexual Health Association (ASHA) to Promote Sexual Health Education


SAN FRANCISCO, Nov. 8, 2023 /PRNewswire/ -- According to the World Health Organization, more than 1 million sexually transmitted infections (STIs) are acquired every day worldwide, the majority of which are asymptomatic but largely treatable. 3Fun, the world's leading dating app for sexually-free singles and partners to meet like-minded people, today announced that it will make monthly donations to the American Sexual Health Association (ASHA), a non-profit voluntary organization dedicated to stopping sexually transmitted diseases (STDs) and their harmful consequences to individuals, families, and communities.

As part of 3Fun's mission to raise awareness for sexual health and freedom, the company will donate a portion of its revenue each month, which is estimated to exceed $10,000, to support ASHA's treatment, education, and advocacy initiatives.

The World Health Organization has stated that "STIs have a direct impact on sexual and reproductive health through stigmatization, infertility, cancers and pregnancy complications and can increase the risk of HIV."

"At 3Fun, we believe sexuality is a natural and healthy part of the human experience that should be celebrated," said Max Ma, Founder and CEO of 3Fun. "ASHA is an organization that shares the same vision of embracing sexuality and health. By supporting ASHA's programs and outreach, we aim to play a role in breaking down the stigma associated with sexual health and promoting the sexual freedom we all deserve."

About 3Fun:

3Fun, with over 10 million downloads and 2.5 million verified active users worldwide, is the leading dating app for sexually-free singles and partners looking to meet like-minded people. 3Fun's safe and inclusive app allows users to freely enter into ethical open relationships, polyamory, or swinging lifestyles, and fosters a non-judgmental environment for individuals to explore their desires. Learn more about 3Fun here: https://www.go3fun.co/

SOURCE 3Fun


These press releases may also interest you

at 18:05
Reality TV Star, Mollie Pearce, Backs Campaign to Tackle Inequalities in Condition That Impacts Millions of People Globally
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 14:06
Red Door Community Raises more than $300,000 at Their Annual Luncheon Celebrating Women Working and Living with Cancer
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

at 14:05
Easy Eats Pandemanila brand Kalihim (Philippine Bread Rolls) recalled due to undeclared egg
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 13:27
Industrial Automation Market In Life Sciences Industry size is set to grow by USD 5.06 bn from 2024-2028, growing global demand for healthcare services to boost the market growth, Technavio
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 11:03
MODULAR ATP Study of the mCRMtm System Meets Primary Safety and Efficacy Endpoints
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

More news about Health...


News published on and distributed by: